KADCYLA 100MG INJECTION

Kadcyla 100mg Injection is indicated for its use in the following conditions:

• Advanced and metastatic breast cancer
• Metastatic gastric cancer

Ado-trastuzumab emtansine (Kadcyla 100mg Injection) works by combining the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug. Once this medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them. This process helps to slow down or stop the growth of cancer, reducing the size of tumors and potentially extending the patient's life.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Kadcyla 100mg Injection and cause undesirable side effects.

• Kadcyla 100mg Injection should be stored in refrigerator at 2°C to 8°C (36°F to 46°F).
• Protected from light.
• Keep it in its original packaging until it is ready to be used.
• Keep reaching out of the reach of children and pets.
• It should be disposed of properly.

Kadcyla 100mg Injection is administered by a healthcare professional in a hospital or clinic setting. The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated. If a dose is missed, it should be taken as soon as possible unless it's almost time for the next scheduled dose, in which case the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose to make up for missed doses.

Kadcyla 100mg Injection can cause side effects like all medications, although not everyone who takes it will experience them. 

Serious:

• Infusion reactions, including fever, chills, rash, or difficulty breathing
• Lung problems, including shortness of breath, cough, or fever
• Heart problems, including heart failure or abnormal heart rhythms
• Severe bleeding or bruising
• Nerve damage, including numbness, tingling, or weakness
• Severe allergic reactions

Common:

• Fatigue
• Nausea
• Constipation
• Muscle or joint pain
• Headache
• Fever
• Low platelet count
• High liver enzyme levels
• Low red blood cell count
• Loss of appetite
• Rash or itching

If you are receiving Ado-Trastuzumab Emtansine, it's important to be proactive in managing your treatment and monitoring your symptoms. Keep communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Use effective birth control during the treatment and at least 7 weeks after the last dose. Immediately contact your healthcare provider in case of any worsening of symptoms or infusion reactions. Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. Being informed and engaged in your treatment can help ensure the best possible outcomes and manage potential risks or complications.